Reductions in body weight were significantly greater with the LY3298176 1.5 mg, 4.5 mg and 10 mg doses versus placebo in MAD HS (LSM difference [95% CI]: -1.75 kg [-3.38, -0.12], -5.09 kg [-6.72, -3.46] and -4.61 kg [-6.21, -3.01], respectively) and doses of 10 mg and 15 mg had a relevant effect in T2DM patients (LSM difference [95% CI]: -2.62 kg [-3.79, -1.45] and -2.07 kg [-3.25, -0.88], respectively
April 16, 2025: Attorneys In Group Zepbound Lawsuit Argue Over How to Diagnose Gastroparesis Attorneys representing people harmed by Zepbound are trying to find common ground on the terms for a gastroparesis diagnosis
The long half-life creates sustained GLP-1 and GIP receptor activation throughout the entire week, maintaining appetite suppression, glucose control, and the metabolic benefits that drive tirzepatide before and after results people talk about
Convenient once-weekly dosing: Easy to use and fits into most lifestyles
This spot is easily accessible, which makes self-injection simpler